课题基金 / 基金详情

Impact of Eliminating a Structural Barrier: Removing Fibrosis Stage Restrictions on HCV Treatment Uptake

Impact of Eliminating a Structural Barrier: Removing Fibrosis Stage Restrictions on HCV Treatment Uptake
消除结构性障碍的影响：消除纤维化阶段对丙肝治疗的限制
批准号：
391346
负责人：
Saeed Sahar Z
金额：
$0.18万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-08-01 至 2019-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=391346&lang=en
关键词：
Co-Infection Difference-In-Differences Direct Acting Antivirals Hepatitis C Hiv Ics Travel Awards Natural Experiment People Who Inject Drugs Vulnerable Populations

项目摘要

项目成果

Saeed Sahar Z的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cures for Hepatitis C (HCV) now exist. Clinical guidelines recommend treatment for everyone. However, because of high costs, treatments have been reserved for people with the most damaged livers (known as significant liver fibrosis). This may prevent youn
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Breaking Barriers: Expanding Syphilis Point-of-care Testing and Immediate Treatment to Meet the Needs of Underserved Communities
The 13th Canadian Symposium on Hepatitis C Virus (CSHCV)
Advancing Syphilis Elimination: Leveraging Public Health and Academic Partnerships to Build Capacity
Liver Fibrosis: Leveraging Novel Statistical Methods to Determine Optimal Screening Strategy for People Living with Type 2 Diabetes
海外基金